[Problems] A compound, which is useful as an active ingredient for a pharmaceutical composition, for example a pharmaceutical composition for treating constipation-type irritable bowel syndrome, atonic constipation and/or functional gastrointestinal disorder, is provided.
[Means for Solution] The present inventors have extensively studied compounds having TRPA1 channel activation activity, and confirmed that an indolinone compound has a TRPA1 channel activation activity, and thus completed the present invention. The indolinone compound of the present invention has a TRPA1 channel activation activity and can be used as an active ingredient of a pharmaceutical composition for preventing and/or treating constipation-type irritable bowel syndrome, atonic constipation and/or functional gastrointestinal disorder or the like.
                            [问题]本发明提供了一种化合物,该化合物可作为药物组合物的活性成分,例如用于治疗便秘型肠易激综合征、失张性便秘和/或功能性胃肠病的药物组合物。
[解决手段]本发明人广泛研究了具有 TRPA1 通道激活活性的化合物,证实一种
吲哚啉酮化合物具有 TRPA1 通道激活活性,从而完成了本发明。本发明的
吲哚啉酮化合物具有 TRPA1 通道激活活性,可用作预防和/或治疗便秘型肠易激综合征、失张性便秘和/或功能性胃肠功能紊乱等疾病的药物组合物的活性成分。